biosimilar

USFDA green-lights first fast-acting insulin biosimilar

The US Food and Drug Administration has approved Merilog as a biosimilar of Novo Nordisk’s product Novolog (insulin aspart) for…

7 hours ago

Walking the IP tightrope between rights, obligations and public health

“Innovation without access does not make sense,” says Dr Carlos Correa, Executive Director of the South Centre and a seasoned…

12 hours ago